The recommended dosage of VABOMERE is 4 grams (meropenem 2 grams and vaborbactam 2 grams) administered every 8 hours by intravenous (IV) infusion over 3 hours in patients 18 years of age and older ...

Patients were randomized 1:1 to receive either cefiderocol or meropenem administered 2g IV every 8 hours for 7 to 14 days in combination with linezolid 600mg IV every 12 hours for at least 5 days.

Peaks for meropenem's degradation products appeared between 1 and 2.1 minutes. The intraday check samples ( n = 10) at 0.3 and 2.5 mg/mL had average coefficients of variation (CVs) of 3.48% and 3. ...

A novel combination that includes ceftriaxone, sulbactam and disodium EDTA, or CSE, was noninferior to meropenem for the treatment of complicated UTIs, or cUTIs, caused by extended-spectrum beta ...

Torres and colleagues randomly assigned adults aged 18 to 90 years to receive 2-hour IV infusions of ceftazidime/avibactam (2,000 mg/500 mg) or 30-minute IV infusions of meropenem (1,000 mg) every ...

Serious TEAEs occurred in 2% of patients treated with cefepime-taniborbactam and 1.8% of patients treated with meropenem. Complete study results will be presented at an upcoming scientific meeting.

All solutions of meropenem (4, 10, and 20 mg/mL) retained over 90% of the initial drug concentration at five days ( Table 1). The 4-mg/mL solutions retained over 93% of the initial concentration ...

In the present study, we analyze the efficacy of prophylaxis with meropenem in patients receiving a matched related donor allogeneic transplant. In total, 38 patients were sequentially treated ...

Meropenem in dose of 20 mg/kg was administrated i.v. in 60 min infusion every 8-12 hours during 10-14 days as monotherapy as a second ... 3100 grams with severe infections due to MDR ...